Understanding Mrs. Nafeesa's Brain Imaging Reports

1. MRI Brain - what it found

"Restricted lesion with FLAIR hyperintensity... in the lentiform nucleus and corona radiata on left side."

• The lentiform nucleus (putamen + globus pallidus) and corona radiata are deep structures under the cortex, supplied by tiny perforating branches called lenticulostriate arteries.
• "Restricted" on DWI (diffusion-weighted imaging) means water molecules inside injured brain cells cannot move freely - this is the classic signature of an acute ischemic infarct (a stroke where blood flow was cut off).
• "FLAIR hyperintensity" appearing alongside it tells the radiologist roughly how old the injury is. In the first few hours, DWI lights up but FLAIR is often still normal; once FLAIR also becomes bright, the stroke is usually somewhere around 6 hours to a few days old - hence the term "late acute" (evolving/recent, not brand new, not yet old/chronic).
• This is a classic lacunar stroke (small, deep infarct less than 1.5-2 cm, caused by disease of the small penetrating arteries rather than a big vessel blockage).

"Hyperintense signal seen in deep white matter of bilateral cerebral hemispheres... suggestive of ischemic lesions."

• This describes scattered white-matter hyperintensities (sometimes called "leukoaraiosis") on both sides of the brain - these are typically older, chronic changes from long-standing small vessel/microvascular disease, very common with age, hypertension, and diabetes. They are separate from (though related to) the new lacunar infarct above.

2. MRA Brain and Neck - what it found

• A hypoplastic A1 segment of the anterior cerebral artery is a fairly common circle-of-Willis variant; the brain usually compensates well through the connecting arteries (Acom), which were reported normal here.
• A hypoplastic vertebral artery is also common - reported in roughly a quarter of the general population - and is usually asymptomatic because the other vertebral artery and the circle of Willis provide collateral flow. It is best thought of as a risk marker rather than a direct cause: some studies suggest it can modestly reduce flow reserve to the posterior brain circulation and has been statistically linked to posterior-circulation strokes/TIAs in certain patients, though the two arteries reported here (left A1 and right vertebral) do not directly explain the left lentiform nucleus infarct, which is fed by the MCA's lenticulostriate branches (reported normal in caliber).

Putting it all together

• Antiplatelet therapy (e.g., aspirin or clopidogrel) for secondary prevention
• Statin therapy and tight blood pressure control
• Screening/optimizing diabetes, lipids, and lifestyle (smoking cessation if applicable)
• The 2024 European Stroke Organisation guideline on cerebral small vessel disease and lacunar stroke emphasizes aggressive vascular risk-factor control (blood pressure, lipids, antiplatelets) as the mainstay of prevention rather than any intervention directed at the hypoplastic vessels themselves, since those are incidental variants, not the culprit lesion.

Management at This Time

1. Acute/subacute phase (she's still within the first days-to-weeks window)

• Thrombolysis (IV alteplase): only relevant if she presented within the early treatment window from symptom onset with a compatible deficit. Since the scan already shows a "late acute" infarct (days old), that window has likely passed - this is worth confirming with the treating team but isn't something to newly start now.
• Antiplatelet therapy started early: aspirin is standard. Because this looks like a minor/lacunar stroke, many centers now use short-term dual antiplatelet therapy (aspirin + clopidogrel) for about 21-90 days, then step down to a single agent long-term - this reduces early recurrence risk in minor stroke/high-risk TIA, per trial evidence such as dual antiplatelet therapy after minor ischemic stroke.
• Blood pressure: in the true hyperacute phase, aggressive BP lowering is avoided to protect brain perfusion. Once past the acute window (as appears to be the case here), gradual BP control is restarted/intensified.
• Watch for early neurological deterioration: a recognized subset of lacunar strokes can worsen over the first 24-72 hours; this is why close inpatient/early outpatient monitoring matters (Werring et al., 2025 systematic review, PMID 39086233).
• Basic stroke workup if not already done: ECG/Holter (to exclude atrial fibrillation, especially relevant given the vascular variants), fasting glucose/HbA1c, lipid profile, renal function, and an echocardiogram if an embolic source is still being considered.

2. Long-term secondary prevention (this is the core, evidence-backed plan)

• Single long-term antiplatelet (e.g., aspirin or clopidogrel) once the short-term dual-therapy window (if used) ends - lifelong.
• Blood pressure control: target systolic <130 mmHg is considered reasonable for lacunar stroke specifically (SPS3 trial evidence, and reflected in Canadian and US guideline tables) - tighter than the older general targets, since this directly reduces recurrent lacunar stroke and slows white matter disease progression.
• High-intensity statin therapy for lipid lowering, regardless of baseline cholesterol level, unless contraindicated.
• Glycemic control if she is diabetic or prediabetic - small vessel disease is strongly driven by chronic hyperglycemia.
• Lifestyle measures: smoking cessation, regular exercise, weight/obesity management, and general cardiovascular-healthy diet - the ESO guideline explicitly recommends these for overall vascular and cognitive health.
• Anticoagulation is NOT indicated unless a separate reason emerges (e.g., atrial fibrillation found on monitoring) - her MRA didn't identify a large-vessel embolic source, consistent with a small-vessel mechanism.

3. Regarding the incidental vascular findings (thin left A1, thin right vertebral artery)

4. Rehabilitation and follow-up

• If she has any residual weakness, sensory change, or speech difficulty, referral to physiotherapy/occupational therapy for rehab is standard.
• Cognitive screening is worth considering over time, since combined lacunar infarcts and bilateral white matter disease are linked to vascular cognitive decline risk.
• Regular follow-up with neurology and primary care to titrate BP/statin/antiplatelet therapy and reinforce lifestyle changes.